Home » Newsletters » BioWorld Science

BioWorld Science

March 5, 2014

View Archived Issues

Genocea Biosciences joins collaboration to characterize T-cell responses to cancer antigens

Ohr Pharmaceutical and Cold Spring Harbor Laboratory to develop trodusquemine

S1 Biopharma to begin phase IIa trial of Orexa for low male sexual desire

Cardium collaborates with Taxus Pharmaceuticals for regenerative therapeutics

BAX as a novel susceptibility gene for Crohn's disease

Dynavax updates status of AstraZeneca collaboration

Northern Manhattan Study links markers of infection and neuroendocrine dysfunction with stroke risk

Tracon and Santen sign agreement for TRC-105 in ophthalmology

Insight Genetics enters triple-negative breast cancer marker collaboration

Biogen Idec disclose new ROR-gamma receptor modulators

Researchers at Roche present novel mGlu5 receptor modulators

Novel HIV integrase inhibitors disclosed by Bristol-Myers Squibb

Australian group divulges new VEGFR inhibitors for cancer

CCFA Microbiome and Genetics Initiatives seek personalized treatments for IBD

Adasuve now available in the U.S.

Forest Laboratories submits NDA for memantine and donepezil combination

Bioheart reports 6-month data from phase I ANGEL trial

Longer-acting clotting factor FVIIa-CTP shows promise, obtains FDA orphan drug designation

Theravance provides update on separation date for its businesses

FDA lifts clinical hold from Oxycyte development program

Cornerstone Pharmaceuticals presents preclinical data on CPI-613 for NSCLC

Enrollment completed in Celladon's CUPID 2 trial for advanced heart failure

Santhera to present data from expanded access program of Raxone for LHON

Xoma will not advance gevokizumab into pivotal program for erosive osteoarthritis of the hand

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...